FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Tizanidine Hydrochloride Capsules
Status: Discontinuation
»Therapeutic Categories: Neurology

Expand all

Endo Pharmaceuticals, Inc. (New 06/30/2021)

Company Contact Information:
800-828-9393, option 5, then option 2

Presentation Posting Date Related Information
2 mg (NDC 49884-611-53) 06/30/2021
4 mg (NDC 49884-719-53) 06/30/2021
6 mg (NDC 49884-765-53) 06/30/2021

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English